Insulin Glargine Compared with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) or SGLT2 Inhibitors Is Associated with Higher Risk of Alzheimer Disease and Alzheimer Disease-Related Dementias (AD/ADRD) in CKD

Amara Sarwal, Guo Wei, Ravinder Singh, Sydney Elizabeth Hartsell, Adam Bress, Catherine G. Derington, Robert E. Boucher, Mckenna R. Nevers, Niharika Katkam, Augustine Takyi, Akhil Ramanujam Chakravartula, Jincheng Shen, Tom Greene, Srinivasan Beddhu

doi:10.1681/asn.2024295x7sw8

Insulin Glargine Compared with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) or SGLT2 Inhibitors Is Associated with Higher Risk of Alzheimer Disease and Alzheimer Disease-Related Dementias (AD/ADRD) in CKD

Authors: Amara Sarwal, Guo Wei, Ravinder Singh, Sydney Elizabeth Hartsell, Adam Bress, Catherine G. Derington, Robert E. Boucher, Mckenna R. Nevers, Niharika Katkam, Augustine Takyi, Akhil Ramanujam Chakravartula, Jincheng Shen, Tom Greene, Srinivasan Beddhu

Published: 2024-10-28

DOI: 10.1681/asn.2024295x7sw8

Keywords: No keywords found.

Abstract:
No abstract found.

Source: